Value20202021202220232024TTMCash from investing activities49.56 M12.69 M8.46 M8.62 M8.13 M12.07 MCash from financing activities91.78 M34.29 M4.19 M10.67 M4.96 M2.01 MFree cash flow39.13 M33.01 M23.61 M38.57 M8.52 M2.89 M
Cerus Corporation
Cerus Corporation is an American multinational biotechnology company headquartered in Concord, California that develops and provides a treatment system to pathogen-reduce human blood products for the healthcare industry.